multiple sclerosis

Going live – immune cell activation in multiple sclerosis
05/22/2013 - 10:21

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to examine individual cells and their activity directly in the tissue. The development of new microscopes and fluorescent dyes in recent years has brought this scientific dream tantalisingly close. Scientists from the Max Planck Institute of Neurobiology in Martinsried have now presented not one, but two studies introducing new indicator molecules which can visualise the activation of T cells.

 

more
Faster biological ageing linked to increased cancer risk
03/28/2013 - 08:51

An international team of scientists involving researchers from Karolinska Institutet has found new evidence that links faster 'biological' ageing to the risk of developing several age-related diseases - including heart disease, multiple sclerosis and various cancers.

 

more
Combination therapy provides similar clinical benefit as single drug treatment in Multiple Sclerosis
03/11/2013 - 12:24

People with multiple sclerosis (MS) who were treated with combination therapy did not see significant clinical benefit over those treated with single drug therapy, but combination therapy did reduce the development of new lesions, according to an international research team led by The Mount Sinai Medical Center. The findings, part of the largest-ever MS trial sponsored by the National Institutes of Health, are published in the March 11 issue of Annals of Neurology.

 

more
Cancer drug Imatinib a possible treatment for Multiple Sclerosis
02/22/2013 - 10:49

A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, which was made by researchers at Karolinska Institutet, might one day lead to better forms of treatment for patients with MS.
Ingrid Nilsson Photo: Stefan Zimmerman

 

more
Unexpected finding about MS‏ - Damaged nerve fibers survive
02/05/2013 - 20:13

Multiple sclerosis, a brain disease that affects over 400,000 Americans, causes movement difficulties and many neurologic symptoms. MS has two key elements: The nerves that direct muscular movement lose their electrical insulation (the myelin sheath) and cannot transmit signals as effectively. And many of the long nerve fibers, called axons, degenerate.

more
Multiple sclerosis study reveals how killer T cells learn to recognize nerve fiber insulators
01/11/2013 - 10:57

Misguided killer T cells may be the missing link in sustained tissue damage in the brains and spines of people with multiple sclerosis, findings from the University of Washington reveal.  Cytoxic T cells, also known as CD8+ T cells, are white blood cells that normally are in the body’s arsenal to fight disease.

more